Obesity trials in Türkiye

In Türkiye 17 Also abroad 1939

17 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Where
Adana, Ankara, Antalya, Istanbul, Izmir, Sariçam
Age
18 years and over
People
1,600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Where
Ankara, Antalya, Center, Istanbul
Age
18 years and over
People
500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00
No phaseTaking people
Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes
Where
Denizli
Age
18 years to 65 years
People
30
Run by
Pamukkale University
See details and how to joinNCT07924436
No phaseTaking people
Ocular Changes in Patients Using Tirzepatide or Semaglutide
Where
Istanbul
Age
18 years and over
People
40
Run by
Istanbul University
See details and how to joinNCT07924618
No phaseTaking people
Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults With Obesity
Where
Van
Age
18 years and over
People
200
Run by
Yuzuncu Yil University
See details and how to joinNCT07901777
Phase 3Taking people
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Where
Ankara, Antalya, Bursa, Eskişehir, Hatay, Istanbul, Izmir, İzmit, Mersin
Age
18 years to 70 years
People
350 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00
Phase 3Taking people
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Where
Ankara, Bursa, Eskişehir, Hatay, Istanbul, Izmir, İzmit, Mersin, Muratpaşa
Age
18 years to 70 years
People
290 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00
Phase 3Not yet taking people in Türkiye
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Where
Adana, Ankara, Antalya, Diyarbakır, Eskişehir, Istanbul, Kayseri, Kocaeli, Yüreğir
Age
45 years to 64 years
People
3,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00
Phase 3Taking people
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Where
Adana, Afyonkarahisar, Ankara, Çorum, Eskişehir, Istanbul, Izmir, Kayseri, Kocaeli, Konya
Age
18 years to 99 years
People
5,056 worldwide
Run by
Amgen
See details and how to joinNCT07037459
Phase 3Taking people
A Study Evaluating Mibavademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in Children, Adolescents and Adults
Where
Ankara, Kayseri
Age
2 years and over
People
4 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT07220772 · EU 2024-518674-14-00
Phase 3Taking people
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Where
Adana, Adapazarı, Ankara, Antalya, Istanbul
Age
18 years and over
People
4,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07667803
Phase 3Taking people
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Where
Alanya/ Antalya, Maltepe/İstanbull, Merkez/Battalgazi/Malatya, Merkez/Çorum, Yenimahalle / Ankara, Yıldırım/Bursa, Yuregir/Adana, Zeytinburnu/İstanbul
Age
18 years and over
People
300 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07571109 · EU 2024-520443-16-00
Phase 3Taking people
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Where
Alanya/ Antalya, Maltepe/İstanbull, Merkez/Battalgazi/Malatya, Merkez/Çorum, Yenimahalle / Ankara, Yıldırım/Bursa, Yuregir/Adana, Zeytinburnu/İstanbul
Age
18 years and over
People
300 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07571005 · EU 2024-520442-36-00
Phase 3Taking people
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Where
Adana, Adapazarı/Sakarya, Afyonkarahisar, Altınordu/Ordu, Ankara, Antalya, Bayraklı/İzmir, Bursa, Çanakkale/Türkiye, Canik/Samsun, Eskişehir, Istanbul, Izmir, Kayseri, Keçiören/Ankara, Kocaeli, Kütahya, Malatya, Merkez/elaziğ, Mersin, Muratpasa/ Antalya, Yakutiye / Erzurum, Yenimahalle/Ankara, Yuregir/Adana
Age
18 years and over
People
5,610 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00
Phase 3Taking people
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Where
Bahçelievler/İstanbul, Çankaya/Ankara, Edirne, Fatih/İstanbul, Yıldırım/Bursa, Yuregir/Adana
Age
18 years and over
People
400 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07509307 · EU 2024-520445-23-00
No phaseTaking people
UNMASK: Unveiling the Pathobiology of Metabolic Dysfunction-Associated Steatotic Liver Disease for the Discovery of Novel Therapeutics and Biomarkers
Where
Ankara
Age
18 years and over
People
450 worldwide
Run by
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
See details and how to joinNCT07652151
Phase 2Taking people
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Where
Adana, Ankara, Gaziantep, Istanbul, Izmir, Kayseri, Kocaeli
Age
18 years and over
People
465 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00